MicroCutter 5/80
Commercial- Indications
- Lung cancer, Thoracic surgery, Cardiac surgery
Company intelligence / Profile preview
Dextera Surgical, formerly known as Cardica, was a medical device company that designed and manufactured proprietary stapling devices for minimally invasive surgical procedures. The company's flagship product, the MicroCutter 5/80, was the world's smallest stapler and cutter, designed to provide greater access and maneuverability in tight surgical spaces such as thoracic and gastrointestinal procedures. Dextera also developed automated anastomosis systems for coronary artery bypass graft (CABG) surgery. Following financial difficulties, the company filed for Chapter 11 bankruptcy in 2017 and its assets were subsequently acquired.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dextera Surgical.